Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas

Blood

Volumn 92, Issue 4, 1998, Pages 1308-1316

  Krenacs, Laszlo ^b   Himmelmann, Andreas W ^b   Quintanilla Martinez, Leticia ^b   Fest, Thierry ^b   Riva, Agostino ^b   Wellmann, Axel ^b   Bagdi, Eniko ^b   Kehrl, John H ^b   Jaffe, Elaine S ^b   Raffeld, Mark ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR AP 1;

ARTICLE; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; FOLLICULAR LYMPHOMA; GENE EXPRESSION REGULATION; HUMAN; LARGE CELL LYMPHOMA; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 0032529326     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1308     Document Type: Article

References (55)

1. Barberis A, Widenhorn K, Vitelli L, Busslinger M: A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev 4:849, 1990
2. Adams B, Dorfler P, Aguzzi A, Kozmik Z, Urbanek P, Maurer-Fogy I, Busslinger M: Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev 6:1589, 1992
3. Singh M, Birshtein BK: NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′ alpha enhancer at early stages of B-cell differentiation. Mol Cell Biol 13:3611, 1993
4. Waters SH, Saikh KU, Stavnezer E: A B-cell-specific nuclear protein that binds to DNA sites 5′ to immunoglobulin Sa tandem repeats is regulated during differentiation. J Mol Cell Biol 9:5594, 1989
5. Xu L, Kim MG, Marcu KB: Properties of B cell stage specific and ubiquitous nuclear factors binding to immunoglobulin heavy chain gene switch regions. Int Immunol 4:875, 1992
6. Williams M, Maizels N: LR1, a lipopolysaccharide-responsive factor with binding sites in the immunoglobulin switch regions and heavy-chain enhancer. Genes Dev 5:2353, 1991
7. Okabe T, Bauer SB, Kudo A: A pre-B- and B-cell-specific DNA binding protein, EBB-1, which binds to the promoter of the VpreB1 gene. Eur J Immunol 22:31, 1992
8. Busslinger M, Urbánek P: The role of BSAP (Pax-5) in B-cell development. Curr Opin Genet Dev 5:595, 1995
9. Max EE, Wakatsuki Y, Neurath MF, Strober W: The role of BSAP in immunoglobulin isotype switching and B-cell proliferation. Curr Top Microbiol Immunol 194:449, 1995
10. Kozmik Z, Wang S, Dörfler P, Adams B, Busslinger M: The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol 12:2662, 1992
11. Wakatsuki Y, Nuerath MF, Max EE, Strober W: The B cell-specific transcription factor BSAP regulates B cell proliferation. J Exp Med 179:1099, 1994
12. Kehrl JH, Riva A, Wilson GL, Thevenin C: Molecular mechanisms regulating CD19, CD20 and CD22 gene expression. Immunol Today 15:432, 1994
13. Urbanek P, Wang Z-Q, Fetka I, Wagner EF, Busslinger M: Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax 5/BSAP. Cell 79:901, 1994
14. Neurath MF, Strober W, Wakatsuk Y: The murine Ig 3′ a enhancer is a target site with repressor function for the B-cell lineage-specific transcription factor BSAP (NF-HB, S-BP). J Immunol 153:730, 1994
15. Neurath MF, Max EE, Strober W: Pax5 (BSAP) regulates the murine immunoglobulin 3′ alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription. Proc Natl Acad Sci USA 92:5336, 1995
16. Chalepakis G, Fritsch R, Fickenscher H, Deutsch U, Goulding M, Gruss P: The molecular basis of the undulated/Pax-1 mutation. Cell 66:873, 1991
17. Walther C, Guenet J-L, Simon D, Deutsch U, Jostes B, Goulding M, Plachov D, Balling R, Gruss P: Pax: A murine multigene family of paired box containing genes. Genomics 11:424, 1991
18. Stapleton P, Weith A, Urbanek P, Kozmik Z, Busslinger M: Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. Nat Genet 3:292, 1993
19. Chalepakis G, Gruss P: Identification of DNA recognition sequences for the Pax3 paired domain. Gene 162:267, 1995
20. Chalepakis G, Stoykova A, Wijnholds J, Tremblay P, Gruss P: Pax: Gene regulators in the developing nervous system. J Neurobiol 24:1367, 1993
21. Strachan T, Read AP: PAX genes. Curr Opin Genet Dev 4:427, 1994
22. Gerard M, Abitbol M, Delezoide AL, Dufier JL, Mallet J, Vekemans M: PAX-genes expression during human embryonic development, a preliminary report. C R Acad Sci III 318:57, 1995
23. Maulbecker CC, Gruss P: The oncogenic potential of Pax genes. EMBO J 12:2361, 1993
24. Poleev A, Fickenscher H, Mundlos S, Winterpacht A, Zabel B, Fidler A, Gruss P, Plachov D: PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development 116:611, 1992
25. Dressler GR, Douglass EC: Pax2 is an DNA-binding protein expressed in embryonic kidney and Wilms'tumor. Proc Natl Acad Sci USA 89:1179, 1992
26. Barr FG, Galili N, Holick J, Biegel JA, Rovera G, Emanuel BS: Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet 3:113, 1993
27. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG: Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54:2869, 1994
28. Davis RJ, Bennicelli JL, Macina RA, Nycum LM, Biegel JA, Barr FG: Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma. Hum Mol Genet 4:2355, 1995
29. Gnarra JR, Dressler GR: Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res 55:4092, 1995
30. Bennicelli JL, Edwards RH, Barr FG: Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Proc Natl Acad Sci USA 93:5455, 1996
31. Kozmik Z, Sure U, Ruedi D, Busslinger M, Aguzzi A: Deregulated expression of PAX5 in medulloblastoma. Proc Natl Acad Sci USA 92:5709, 1995
32. Stuart ET, Kioussi C, Aguzzi A, Gruss P: Pax5 expression correlates with increasing malignancy in human astrocytomas. Clin Cancer Res 1:207, 1995
33. Stuart ET, Haffner R, Oren M, Gruss P: Loss of p53 function trough PAX-mediated transcriptionan repression. EMBO J 14:5638, 1995
34. Iida S, Rao PH, Nallasivam P, Hibshoosh H, Butler M, Louie DC, Dyomin V, Ohno H, Chaganti RSK, Dalla-Favara R: The t(9;14) (p13;q32) chromosomal translocation associated with lymphoplasmocytoid lymphoma involves the PAX-5 gene. Blood 88:4110, 1996
35. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles TM, Mason DY, Muller-Hermelink H-K, Pileri SA, Pins MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
36. Krenacs L, Harris CA, Raffeld M, Jaffe ES: Immunohistochemical diagnosis of T-cell lymphomas in paraffin sections. J Cell Pathol 1:125, 1996
37. Krenacs L, Wellmann A, Sorbara L, Himmelmann AW, Bagdi E, Jaffe ES, Raffeld M: Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: Evidence for distinct cellular origin. Blood 89:980, 1997
38. Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ: Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88:1054, 1996
39. Dorfler P, Busslinger M: C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. EMBO J 15:1971, 1996
40. Hodgkin PD, Lee J-H, Lyons AB: B cell differentiation and isotype switching is related to division cycle number. J Exp Med 184:277, 1996
41. Martinez-Valdez H, Malisan F, de Bouteiller O, Guret C, Banchereau J, Liu YJ: Molecular evidence that isotype switching occurs within the germinal centers. Ann NY Acad Sci 764:151, 1995
42. Schmid C, Isaacson PG: Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): An immunophenotypic study. Histopathology 24:445, 1994
43. Malisan F, Fluckiger A-C, Ho S, Guret C, Banchereau J, Martinez-Valdez H: B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro. Blood 87:717, 1996
44. Dunn-Walters DK, Isaacson PG, Spencer J: Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med 182:559, 1995
45. H genes from microdissected human Peyer's patch marginal zone B cells. Immunology 88:618, 1996
46. Kuppers R, Hajadi M, Plank L, Rajewsky K, Hansmann ML: Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human. Eur J Immunol 26:1794, 1996
47. Mahmoud MS, Huang N, Nobuyoshi M, Lisukov IA, Tanaka H, Kawano MM: Altered expression of Pax-5 gene in human myeloma cells. Blood 87:4311, 1996
48. Davis RE, Dorfman RF, Warnke RA: Primary large-cell lymphoma of the thymus: A diffuse B-cell neoplasm presenting as primary mediastinal lymphoma. Hum Pathol 21:1262, 1990
49. Kanavaros P, Gaulard P, Charlotte F, Martin N, Ducos C, Lebezu M, Mason DY: Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas. Am J Pathol 146:735, 1995
50. Hsu S-M, Hsu P-L: The nature of Reed-Sternberg cells: Phenotype, genotype, and other properties. Crit Rev Oncogene 5:213, 1994
51. Tamaru J, Hummel M, Zemlin M, Kalvelage B, Stein H: Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. Blood 84:708, 1994
52. Orazi A, Jiang B, Lee CH, English GW, Cattoretti G, John K, Neiman RS: Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease. Am J Clin Pathol 104:413, 1995
53. Offit K, Parsa N, Filippa D, Jhanwar S, Chaganti RSK: t(9; 14)(p13;q32) denotes a subset of low grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 80:2594, 1992
54. Busslinger M, Klix N, Pfeffer P, Graninger PG, Kozmik Z: Deregulation of PAX-5 by translocation of the Eμ enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lynphoma. Proc Natl Acad Sci USA 93:6129, 1996
55. Pilz A, Fountain J, Peters J, Abbott C: Linkage mapping of the Aldo-2, Pax-5, Ambp, and D4h9S3E loci on mouse chromosome 4 in the region of homology with human chromosome 9. Genomics 18:705, 1993